Recurrent Breast Cancer Recruiting Phase 3 Trials for Anastrozole (DB01217)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs